about
Renal resistive index as a marker of vascular damage in cardiovascular diseasesRenal perfusion index reflects cardiac systolic function in chronic cardio-renal syndrome.Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.Hemodynamic characteristics and the occurrence of renal biopsy-related arteriovenous fistulas in native kidneys.Doppler tissue perfusion parameters in recognizing pancreatic malignant tumors.Ultrasonic evaluation of renal cortex arterial area enables differentiation between hypertensive and glomerulonephritis-related chronic kidney disease.Infective endocarditis in the course of urosepsis E. coli ESBL(+) in a patient with Goodpasture's syndrome.Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension.Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.Membranoproliferative glomerulonephritis, mantle cell lymphoma infiltration, and acute kidney injury.[Advances in diagnosis and treatment of AL amyloidosis].[Acute cardiorenal syndrome: recovery of renal function after renal replacement therapy].Dynamic tissue perfusion assessment reflects associations between antihypertensive treatment and renal cortical perfusion in patients with chronic kidney disease and hypertension.[Renal resistive index--does it extend diagnostic possibilities in nephrology?].[The treatment of septic shock with continuous venovenous hemodialysis using high cut-off dialyzer in patient after immediate circulatory arrest].Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.Impact of cardiovascular organ damage on cortical renal perfusion in patients with chronic renal failureNieskuteczne leczenie przyspieszonej fazy nadciśnienia tętniczego i utrzymującego się stanu krążenia hiperkinetycznego u pacjenta hemodializowanego z wysokoprzepływową przetoką tętniczo-żylnąAtypical clinical presentation of Churg-Strauss syndrome with rapidly progressive glomerulonephritis: case report[Influence of controlled hypotensive therapy on renal autoregulation efficiency in the doppler captopril test in patients with chronic glomerulonephritis][Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis][Atherosclerotic or hypertensive nephropathy--case report][Effectiveness of subcutaneous and intravenous epoetin alpha in haemodialysed patients][Influence of parathormone level on the doses of human recombinant erythropoietin in haemodialysed patients][Usefulness of ultrasonographic renal resistive index in monitoring efficacy of hypotensive in haemodialysed patients--case report][Doppler sonography assessment of renal arteries against the cardiovascular risk factors in young men--preliminary report]
P50
Q26991879-30613508-0530-4102-9554-135845C22408Q35545665-9129561A-F56E-476C-91D2-B2C171828BDAQ36942610-373B3F70-0367-43C1-8FFE-2EE9B145F2A3Q37273530-57179472-4EE2-4C67-BB0A-44F3C1757D98Q39182171-865DA331-DE36-4315-99B6-55D404FCC38AQ40176511-89F6F876-FD28-45E4-8E62-B511C41FC883Q41035376-461468B8-6DA9-4695-8419-16378F69C9A6Q41412855-84A92AEA-69B7-493C-8F41-4A5CC28E2B06Q42214939-E089EC67-989C-40BF-A96C-0C0336AB20F1Q42912350-DF72873E-8E10-4CF0-8CA2-86B444CE4703Q46478577-1B1F5AD7-0EBD-4C2F-892E-604311A09463Q46897761-33137390-A5B8-4080-BB0F-77729D172467Q48156545-377E4FC3-CE1D-4AE6-B9BB-42E058090F97Q53876737-4836844C-F88E-4A87-B5A0-CB1DD921EC65Q54327574-B0379413-B710-4CAC-9492-77FF5097C0A1Q55280828-141F06AE-1D03-4747-AEEF-2D10F3B56C38Q58920559-E6BEBEAE-CF9A-455E-8F2C-5F9250EAF4D3Q61922677-64B10B62-1508-47E7-8D8E-ED4EA55830BFQ61922684-17F9CE43-F3F7-409D-80BC-D8F752748484Q61922695-3496B670-A343-4FA9-8195-0F6C0510D363Q61922696-DB7E7C84-29B6-4010-9BD1-7033E786A660Q61922699-B78423FC-706D-4EFF-888F-99917778B423Q61922701-3EB4C00E-8B59-4F1A-98CD-6C316E30E896Q61922702-69D2864C-DF82-443F-9D63-A6DC2B4D9A6DQ61922703-C715DFDA-9070-43D9-A84A-8ED91CF77102Q61922705-D4624E91-BACF-431B-B482-3705C62A3C6B
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Arkadiusz Lubas
@ast
Arkadiusz Lubas
@en
Arkadiusz Lubas
@es
Arkadiusz Lubas
@nl
type
label
Arkadiusz Lubas
@ast
Arkadiusz Lubas
@en
Arkadiusz Lubas
@es
Arkadiusz Lubas
@nl
prefLabel
Arkadiusz Lubas
@ast
Arkadiusz Lubas
@en
Arkadiusz Lubas
@es
Arkadiusz Lubas
@nl
P214
P106
P1695
P21
P214
P31
P496
0000-0002-3248-4615
P735
P7859
viaf-311811615